Cipla Limited, a leading pharmaceutical company, has announced its decision to further invest approximately INR 42 crore in digital tech company GoApptiv Private Limited. This investment aligns with Cipla’s strategic vision to bolster its presence across the healthcare continuum, particularly in underserved regions, by enhancing access to essential treatments.

With the completion of this deal, Cipla’s total stake in GoApptiv will increase to 22.99% on a fully diluted basis, marking Cipla’s third investment in the company. The investment will be made through a combination of equity shares and compulsorily convertible preference shares. GoApptiv has seen considerable growth in underpenetrated areas and product lines following Cipla’s previous investments in 2022 and 2020.

Umang Vohra, MD and Global CEO of Cipla Limited, commented on the development, emphasizing the impact of the partnership with GoApptiv. “Our long-standing partnership with GoApptiv has helped us increase penetration in underserved rural areas of India and address critical healthcare gaps where pharmaceutical coverage is limited,” he stated. “In this era of technology-driven healthcare, this expanded investment will help us deliver patient-centric solutions and further strengthen our digitisation agenda to drive Cipla’s next phase of growth.”

GoApptiv’s use of technology in providing quality and affordable healthcare resonates with Cipla’s commitment to making a positive impact on communities through innovative solutions. This current investment round will further reinforce the partnership with GoApptiv in addressing healthcare disparities in underserved regions of India. It represents Cipla’s dedication to integrating digital advancements in healthcare, ensuring more widespread access to vital medical treatments and services.

Cipla’s strategic investment in GoApptiv is a significant step towards enhancing healthcare access and quality, particularly in rural and underserved areas of India. It underscores the growing importance of digital technology in the healthcare sector and Cipla’s role as a frontrunner in leveraging these advancements for broader social impact and improved health outcomes.

  Cipla, GoApptiv, India, Umang Vohra